Related Experiment Videos
17-Ketosteroids in leprosy
Summary
Leprosy patients with liver damage showed lower urinary 17-ketosteroid levels, particularly in males. This suggests a link between liver health and steroid excretion in lepromatous leprosy.
Area of Science:
- Endocrinology
- Hepatology
- Infectious Diseases
Background:
- Leprosy, particularly lepromatous leprosy, can affect various organ systems.
- Liver involvement is a known complication in leprosy patients.
- Urinary 17-ketosteroids are metabolites of androgens and can reflect endocrine and metabolic status.
Purpose of the Study:
- To investigate the relationship between urinary 17-ketosteroid levels and liver function in lepromatous leprosy.
- To explore the correlation between histopathologic findings, serum G.G.P.T. values, and urinary 17-ketosteroids.
Main Methods:
- Estimation of urinary 17-ketosteroids in 29 lepromatous leprosy patients.
- Analysis of histopathologic findings.
- Measurement of serum G.G.P.T. (Glutamic-pyruvic transaminase) values.
Main Results:
- Lower urinary 17-ketosteroid values were observed in cases with definite leproma affecting the liver.
- A correlation was found between decreased 17-ketosteroid levels and indicators of liver damage.
- This association was more pronounced in male patients compared to females.
Conclusions:
- Liver damage in lepromatous leprosy is associated with reduced urinary 17-ketosteroid excretion.
- Urinary 17-ketosteroid levels may serve as an indicator of liver involvement in leprosy.
- Gender influences the relationship between liver damage and steroid metabolism in leprosy.